A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity.
Huang, Yao
A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity. [electronic resource] - Oncotarget Nov 2016 - 78577-78590 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.12480 doi
Adult
Aged
Antibodies, Monoclonal, Humanized--pharmacology
Antineoplastic Agents, Immunological--pharmacology
Biosensing Techniques
Breast Neoplasms--drug therapy
Case-Control Studies
Cell Adhesion--drug effects
Cell Line, Tumor
Dose-Response Relationship, Drug
Epidermal Growth Factor--pharmacology
Female
Humans
Middle Aged
Receptor, ErbB-2--agonists
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Reproducibility of Results
Signal Transduction--drug effects
Tumor Cells, Cultured
A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity. [electronic resource] - Oncotarget Nov 2016 - 78577-78590 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.12480 doi
Adult
Aged
Antibodies, Monoclonal, Humanized--pharmacology
Antineoplastic Agents, Immunological--pharmacology
Biosensing Techniques
Breast Neoplasms--drug therapy
Case-Control Studies
Cell Adhesion--drug effects
Cell Line, Tumor
Dose-Response Relationship, Drug
Epidermal Growth Factor--pharmacology
Female
Humans
Middle Aged
Receptor, ErbB-2--agonists
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Reproducibility of Results
Signal Transduction--drug effects
Tumor Cells, Cultured